MedPath

Clinical Trial of Oral Midazolam in Pediatric Endoscopy

Phase 4
Completed
Conditions
Endoscopy
Interventions
Registration Number
NCT00636428
Lead Sponsor
Tabriz University
Brief Summary

The objective of our study was to compare the safety and efficacy of oral midazolam during pediatric endoscopy.

Detailed Description

Although gastrointestinal endoscopy is widely accepted as fundamental to the diagnosis and treatment of digestive disorders in children, considerable controversy and practice differences persist with respect to the methods and agents used to achieve optimal endoscopic sedation.

Comparison:oral midazolam vs midazolam IV in sedation and comfort scale of pediatric endoscopy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • All of patients scheduled for endoscopy participated in the study.
Read More
Exclusion Criteria

Exclusion criteria were as follows:

  • Children younger than 3 years;
  • Children with significant neurological disability;
  • Children with a history of allergies to benzodiazepines, or to their components;
  • Children with metabolic, cardiac or renal disease; children with previous - Complications to IV sedation;
  • Children with respiratory distress
  • Age under 1 mo and bigger than 17y
  • History of erythromycin used in 4 week ago
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1MidazolamOral midazolam
2MidazolamIV Midazolam
Primary Outcome Measures
NameTimeMethod
efficacy and safety of endoscopy in children with used midazolam
Secondary Outcome Measures
NameTimeMethod
The level of sedation
patient complications, ease of performing the procedure, time of preparation, time for recovery

Trial Locations

Locations (1)

Liver &Gastrointestinal Research center of tabriz medical university

🇮🇷

Tabriz, East Azarbijan, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath